RACHEL LYNCH: Open Payments
NPI 1801354071 · STUART, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$927 in 52 payments from 13 companies in 2025. Trend: 2023 $881 · 2024 $860 · 2025 $927
Food & beverage: $927
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $145 |
| Novo Nordisk Inc | 11 | $144 |
| ABBVIE INC. | 7 | $142 |
| PFIZER INC. | 5 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Lilly USA, LLC | 4 | $70 |
| Amgen Inc. | 3 | $50 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Astellas Pharma US Inc | 2 | $48 |
| Medtronic, Inc. | 2 | $39 |
Products named: NURTEC ODT, Wegovy, CAPLYTA, AIRSUPRA, UBRELVY, QULIPTA, MOUNJARO, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
